All In Biotech

Drug Trial Radar · NCT02727660

A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)

A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD

Last checked: Nov 19, 2026Latest source record: Sep 26, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,876 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,876

Actual

Start

Apr 29, 2016

Primary completion

Apr 4, 2018

Study completion Apr 4, 2018

Sponsor

Lead sponsor
Pearl Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Apr 4, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase III randomized, double-blind, parallel group, multi-center, 52-week COPD exacerbation and lung function study with PT009 320/9.6 μg, PT009 160/9.6 μg and PT005 9.6 μg, all administered BID.

Conditions

  • Chronic Obstructive Pulmonary Disorder

Interventions

  • BFF MDI (PT009) 320/9.6 μgDrug

    Blinded Treatment

  • BFF MDI (PT009) 160/9.6 μgDrug

    Blinded Treatment

  • FF MDI (PT005) 9.6 μgDrug

    Blinded Treatment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Morning Pre-dose Trough FEV1Time frame: at Week 12

Locations

282 sites in 19 countries. Site status is shown where the registry gives one.

  • Research Site

    Dothan, Alabama

  • Research Site

    Huntsville, Alabama

  • Research Site

    Sheffield, Alabama

  • Research Site

    Flagstaff, Arizona

  • Research Site

    Costa Mesa, California

  • Research Site

    Gold River, California

  • Research Site

    Lincoln, California

  • Research Site

    Long Beach, California

  • Research Site

    Palo Alto, California

  • Research Site

    San Diego, California

  • Research Site

    San Diego, California

  • Research Site

    San Diego, California

  • Research Site

    Upland, California

  • Research Site

    Yorba Linda, California

  • Research Site

    Boulder, Colorado

  • Research Site

    Denver, Colorado

  • Research Site

    New Haven, Connecticut

  • Research Site

    Boynton Beach, Florida

  • Research Site

    Chiefland, Florida

  • Research Site

    Clearwater, Florida

  • Research Site

    Daytona Beach, Florida

  • Research Site

    Hialeah, Florida

  • Research Site

    Kissimmee, Florida

  • Research Site

    Leesburg, Florida

  • Research Site

    Lehigh Acres, Florida

  • Research Site

    Merritt Island, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Orlando, Florida

  • Research Site

    Ormond Beach, Florida

  • Research Site

    Port Orange, Florida

  • Research Site

    Sarasota, Florida

  • Research Site

    Tampa, Florida

  • Research Site

    Tampa, Florida

  • Research Site

    Winter Park, Florida

  • Research Site

    Atlanta, Georgia

  • Research Site

    Dacula, Georgia

Showing 40 of 282 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.